Cargando…

Tumor-derived ILT4 induces T cell senescence and suppresses tumor immunity

BACKGROUND: Current immunotherapies including checkpoint blockade therapy have limited success rates in certain types of cancers. Identification of alternative checkpoint molecules for the development of effective strategies for tumor immunotherapy is urgently needed. Immunoglobulin-like transcript...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gao, Aiqin, Liu, Xia, Lin, Wenli, Wang, Jingnan, Wang, Shuyun, Si, Fusheng, Huang, Lan, Zhao, Yangjing, Sun, Yuping, Peng, Guangyong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2021
Materias:	Basic Tumor Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7929805/ https://www.ncbi.nlm.nih.gov/pubmed/33653799 http://dx.doi.org/10.1136/jitc-2020-001536

Ejemplares similares

Blockades of effector T cell senescence and exhaustion synergistically enhance antitumor immunity and immunotherapy
por: Liu, Xia, et al.
Publicado: (2022)

Citrate Promotes Excessive Lipid Biosynthesis and Senescence in Tumor Cells for Tumor Therapy
por: Zhao, Yangjing, et al.
Publicado: (2021)

MDSCs-derived GPR84 induces CD8(+) T-cell senescence via p53 activation to suppress the antitumor response
por: Liu, Jinyan, et al.
Publicado: (2023)

Tumor cell-induced macrophage senescence plays a pivotal role in tumor initiation followed by stable growth in immunocompetent condition
por: Wada, Haruka, et al.
Publicado: (2023)

Therapy of lymphoma by immune checkpoint inhibitors: the role of T cells, NK cells and cytokine-induced tumor senescence
por: Ahmetlic, Fatima, et al.
Publicado: (2021)

ILT4 in Colorectal Cancer Cells Induces Suppressive T Cell Contexture and Disease Progression
por: Yang, Zijiang, et al.
Publicado: (2021)

PPARγ activation modulates the balance of peritoneal macrophage populations to suppress ovarian tumor growth and tumor-induced immunosuppression
por: Prat, Mélissa, et al.
Publicado: (2023)

Overexpressed immunoglobulin-like transcript (ILT) 4 in lung adenocarcinoma is correlated with immunosuppressive T cell subset infiltration and poor patient outcomes
por: Li, Qing, et al.
Publicado: (2020)

Bispecific antibody targeting TROP2xCD3 suppresses tumor growth of triple negative breast cancer
por: Liu, Huicheng, et al.
Publicado: (2021)

Tumor-associated macrophage-specific CD155 contributes to M2-phenotype transition, immunosuppression, and tumor progression in colorectal cancer
por: Zhu, Xudong, et al.
Publicado: (2022)

Dendritic cell-mediated cross presentation of tumor-derived peptides is biased against plasma membrane proteins
por: Fessenden, Tim B, et al.
Publicado: (2022)

Differences in TCR repertoire and T cell activation underlie the divergent outcomes of antitumor immune responses in tumor-eradicating versus tumor-progressing hosts
por: Woolaver, Rachel A, et al.
Publicado: (2021)

Targeted delivery of miR-99b reprograms tumor-associated macrophage phenotype leading to tumor regression
por: Wang, Liang, et al.
Publicado: (2020)

Chordoma recruits and polarizes tumor-associated macrophages via secreting CCL5 to promote malignant progression
por: Xu, Jiuhui, et al.
Publicado: (2023)

Host genetics and tumor environment determine the functional impact of neutrophils in mouse tumor models
por: van Elsas, Marit, et al.
Publicado: (2020)

Combinations of Toll-like receptor 8 agonist TL8-506 activate human tumor-derived dendritic cells
por: He, Mi, et al.
Publicado: (2022)

ANXA1-derived peptide for targeting PD-L1 degradation inhibits tumor immune evasion in multiple cancers
por: Yu, Zheng-Zheng, et al.
Publicado: (2023)

Wilms tumor reveals DNA repair gene hyperexpression is linked to lack of tumor immune infiltration
por: Higgs, Emily F, et al.
Publicado: (2022)

TSH-TSHR axis promotes tumor immune evasion
por: Wu, Zhenghao, et al.
Publicado: (2022)

TGFβ-derived immune modulatory vaccine: targeting the immunosuppressive and fibrotic tumor microenvironment in a murine model of pancreatic cancer
por: Perez-Penco, Maria, et al.
Publicado: (2022)

TFEB is a master regulator of tumor-associated macrophages in breast cancer
por: Li, Yong, et al.
Publicado: (2020)

HDAC9 deficiency promotes tumor progression by decreasing the CD8(+) dendritic cell infiltration of the tumor microenvironment
por: Ning, Yongling, et al.
Publicado: (2020)

Local IFNα enhances the anti-tumoral efficacy of systemic anti-PD1 to prevent tumor relapse
por: Guerin, Marion v, et al.
Publicado: (2020)

Heat shock and HSP70 regulate 5-FU-mediated caspase-1 activation in myeloid-derived suppressor cells and tumor growth in mice
por: Pilot, Thomas, et al.
Publicado: (2020)

ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation
por: Chen, Xiaozheng, et al.
Publicado: (2021)

Tumor-associated Tregs obstruct antitumor immunity by promoting T cell dysfunction and restricting clonal diversity in tumor-infiltrating CD8+ T cells
por: Noyes, David, et al.
Publicado: (2022)

Antimetabolite pemetrexed primes a favorable tumor microenvironment for immune checkpoint blockade therapy
por: Lu, Chia-Sing, et al.
Publicado: (2020)

CD200 promotes immunosuppression in the pancreatic tumor microenvironment
por: Choueiry, Fouad, et al.
Publicado: (2020)

Lactoferrin-containing immunocomplex mediates antitumor effects by resetting tumor-associated macrophages to M1 phenotype
por: Dong, Hongliang, et al.
Publicado: (2020)

AR-A014418 regulates intronic polyadenylation and transcription of PD-L1 through inhibiting CDK12 and CDK13 in tumor cells
por: Zhang, Ganggang, et al.
Publicado: (2023)

LINC01140 promotes the progression and tumor immune escape in lung cancer by sponging multiple microRNAs
por: Xia, Rongmu, et al.
Publicado: (2021)

T lymphocytes induce human cancer cells derived from solid malignant tumors to secrete galectin-9 which facilitates immunosuppression in cooperation with other immune checkpoint proteins
por: Schlichtner, Stephanie, et al.
Publicado: (2023)

Tumor CEMIP drives immune evasion of colorectal cancer via MHC-I internalization and degradation
por: Zhang, Biying, et al.
Publicado: (2023)

PD-1 does not mark tumor-infiltrating CD8+ T cell dysfunction in human gastric cancer
por: Shen, Yang, et al.
Publicado: (2020)

Remodeling tumor immune microenvironment (TIME) for glioma therapy using multi-targeting liposomal codelivery
por: Zheng, Zening, et al.
Publicado: (2020)

Tumor-associated neutrophils and macrophages interaction contributes to intrahepatic cholangiocarcinoma progression by activating STAT3
por: Zhou, Zhengjun, et al.
Publicado: (2021)

Regulation of tumor growth by leukocyte-specific protein 1 in T cells
por: Kwon, Riri, et al.
Publicado: (2020)

Progesterone promotes immunomodulation and tumor development in the murine mammary gland
por: Werner, Lauryn R, et al.
Publicado: (2021)

Tumor ablation plus co-administration of CpG and saponin adjuvants affects IL-1 production and multifunctional T cell numbers in tumor draining lymph nodes
por: Raaijmakers, Tonke K, et al.
Publicado: (2020)

BT7480, a novel fully synthetic Bicycle tumor-targeted immune cell agonist™ (Bicycle TICA™) induces tumor localized CD137 agonism
por: Hurov, Kristen, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_596u9djhnh56ir0n1ruptuuhbp